Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

• Published in: Clinical lymphoma, myeloma and leukemia Vol. 15; pp. S206 - S207
• Main Authors: Jaglowski, Samantha M., MD, MPH, Jones, Jeffrey A., MD, MPH, Flynn, Joseph M., DO, MPH, Andritsos, Leslie A., MD, Maddocks, Kami J., MD, Woyach, Jennifer A., MD, Blum, Kristie A., MD, Grever, Michael R., MD, Geyer, Susan Michelle, PhD, Heerema, Nyla A., PhD, Lozanski, Gerard, MD, Stefanos, Mona, BS, Hall, Nathan, MD, PhD, Nagar, Veena, MD, Munneke, Brian, PhD, West, Jamie-Sue, Neuenburg, Jutta K., MD, PhD, James, Danelle F., MD, MAS, Johnson, Amy J., PhD, Byrd, John C., MD
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-06-2015
• Subjects: Hematology, Oncology and Palliative Medicine
• ISSN: 2152-2650; 2152-2669
• DOI: 10.1016/j.clml.2015.04.069